IWC
RPRX icon

Integrated Wealth Concepts’s Royalty Pharma RPRX Stock Holding History

Integrated Wealth Concepts’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$863K Buy
15,385
+1,907
+14% +$99.3K 0.01% 1305
2026
Q1 		$647K Buy
+13,478
New +$590K 0.01% 1394

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Integrated Wealth Concepts's RPRX Position: Q2 2026 in Review

Integrated Wealth Concepts increased its Royalty Pharma (RPRX) stake by 14% in Q2 2026, buying an estimated $99.3K and bringing the position to 15,385 shares worth $863K. The position accounts for 0.01% of the portfolio, ranked #1305.

Integrated Wealth Concepts first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Integrated Wealth Concepts held 15,385 shares of Royalty Pharma worth $863K as of Q2 2026.
  • Integrated Wealth Concepts bought 1,907 Royalty Pharma shares in Q2 2026, an estimated $99.3K.
  • Royalty Pharma made up 0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #1305 holding.
  • Integrated Wealth Concepts first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.